Immunovant Stock (NASDAQ: IMVT) stock price, news, charts, stock research, profile.
You can purchase shares of Immunovant (NASDAQ:IMVT) through any online brokerage.
Other companies in Immunovant’s space includes: Twist Bioscience (NASDAQ:TWST), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX) and Alkermes (NASDAQ:ALKS).
Immunovant has a consensus price target of $40.53.
The stock price for Immunovant (NASDAQ: IMVT) is $26.08 last updated December 24, 2024 at 1:13 PM EST.
There are no upcoming dividends for Immunovant.
Immunovant’s Q3 earnings are confirmed for Monday, February 10, 2025.
There is no upcoming split for Immunovant.
Immunovant is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.